C

Cheil Bio Co Ltd
KOSDAQ:052670

Watchlist Manager
Cheil Bio Co Ltd
KOSDAQ:052670
Watchlist
Price: 2 080 KRW -9.96% Market Closed
Market Cap: 60.6B KRW

Net Margin
Cheil Bio Co Ltd

-2.4%
Current
-10%
Average
4.5%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-2.4%
=
Net Income
-181.9m
/
Revenue
7.6B

Net Margin Across Competitors

No Stocks Found

Cheil Bio Co Ltd
Glance View

Market Cap
57B KRW
Industry
Pharmaceuticals

Cheil Bio Co., Ltd. engages in the manufacture and sale of veterinary products for pigs, cattle, chickens, cows, and aquatic animals. The company is headquartered in Ansan, Gyeonggi-Do and currently employs 43 full-time employees. The company went IPO on 2002-01-24. The firm's offerings consist of antibiotics, antimicrobials, lactobacillus, enzyme preparations, parasiticides, antiseptics, organic trace minerals, vaccines, diagnostic kits including enzyme-linked immunosorbent assay (ELISA) test kits, virus test kits and deoxyribonucleic acid (DNA) kits, as well as feed additives. The Company’s products are used for cattle, pigs, chickens, pets and other animals. The company supplies its products mainly to the domestic market.

Intrinsic Value
722.26 KRW
Overvaluation 65%
Intrinsic Value
Price
C
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-2.4%
=
Net Income
-181.9m
/
Revenue
7.6B
What is the Net Margin of Cheil Bio Co Ltd?

Based on Cheil Bio Co Ltd's most recent financial statements, the company has Net Margin of -2.4%.

Back to Top